Showing results (201-210 of 231) with videos related to

Sort By:
Pageof 24
Urology|May 1, 1989
Patients' choice of treatment in stage D prostate cancerB R Cassileth, M S Soloway, N J Vogelzang, et al.
The Journal of Urology|December 22, 1999
Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of gradeV B Lokeshwar, C Obek, H T Pham, et al.
The Journal of Urology|May 24, 2001
Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancerS H Hautmann, V B Lokeshwar, G L Schroeder, et al.
Cancer|April 1, 1995
Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patientsF Civantos, M A Marcial, E R Banks, et al.
Urology|August 1, 1995
Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study GroupN J Vogelzang, G W Chodak, M S Soloway, et al.
Cancer Treatment Reports|February 1, 1980
Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim reportM D DeFuria, R B Bracken, D E Johnson, et al.
Urology|January 11, 1991
Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study GroupM S Soloway, G Chodak, N J Vogelzang, et al.
BJU International|June 15, 1999
Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancerM F Sarosdy, P F Schellhammer, M S Soloway, et al.
Southern Medical Journal|November 1, 1983
Use of tumor colony assay in clinical oncologyH B Niell, C L Neely, C A Wood, et al.
JAMA|August 21, 1987
Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgeryW U Shipley, G R Prout, A B Einstein, et al.
Pageof 24